Your Results May Vary For HCV Treatment
According to this study, actual treatment results may be only half as good as touted. Doctors tend to trust the... View Article
Continue reading »Research & Treatment News
Share
Follow Us
More HCV Treatment News Coverage
The Los Angeles Times is one of the largest daily newspapers in the U.S. Their interest in HCV is indicative of a growing awareness of the extent of the disease in this country. The article clearly focuses on the hope of safer, more effective treatments than what is now available.
Continue reading »Japanese Researchers Make Progress
This article is from one of the largest Japanese newspapers. As it shows, researchers in Japan are also working hard to develop a better treatment for HCV. Scientists the world over are doing their best to find a less toxic and more effective treatment.
Continue reading »VX-950 Making Progress
Here’s an exciting one, VX-950 we’ve been watching for a while. This protease inhibitor is making good progress (and is... View Article
Continue reading »Another Biotech Contender
Here is another compound from a biotech pharmaceutical company. This antisense approach has been spoken of with great promise. We look forward to seeing how it proceeds. We'll stay tuned to this one...
Continue reading »A Good HCV Newspaper Article
This is one of the best general audience articles we’ve come across on HCV in quite a while. There is... View Article
Continue reading »Zandaxin Announcement December 2005
Phase 3 Trials are very advanced. If it works, Zandaxin is another enhancement for Interferon therapy. We are looking forward to alternatives to Interferon therapy, but this could be a very positive advance for patients who would consider Interferon and benefit from it. Especially considering that these tests are focused on non-responders, who currently have little recourse but to protect and support their livers with clinically proven natural approaches.
Continue reading »New Drug, Actilon, In Development
Another new approach in the pipeline. As we've always said, with millions of people infected, the drug and biotech companies are falling over each other to come up with viable treatments to improve on what is currently available.
Continue reading »Another Treatment Development Alliance
Alnylam to align with West Coast firm on hep C treatment Boston Business Journal Alnylam Pharmaceuticals Inc. and a California... View Article
Continue reading »Report Claims MOST HCV Patients Will Develop Cirrhosis
Sep 2, 2005
1 Comment
This is one of the most broad announcements regarding Hepatitis C I’ve seen in a long time. It appears to... View Article
Continue reading »
